ESR1 and breast carcinoma: Our study clearly demonstrated that USP35 promotes the growth of ER+ breast cancer cells in vitro and in vivo, which is consistent with higher USP35 expression in breast tumors compared with adjacent normal breast tissues (Figs. 1a, d).